CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Health Communications

Health Communications is a Deerfield Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Analytics For Life

Analytics 4 Life® is pioneering digital health using artificial intelligence to develop a completely new form of medical imaging. With an initial focus on coronary artery disease and pulmonary hypertension, Analytics 4 Life is advancing a novel, radiation-free, and exercise-free cardiac imaging technology aimed at improving existing care pathways. Analytics 4 Life is based in Toronto with U.S. headquarters in Research Triangle Park, NC.

Passport Health Northeast Pennsylvania

Passport Health Northeast Pennsylvania is a Bethlehem, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dental Technologies

Dental Technologies, Inc is a company specializing in the research, formulation, compounding and packaging of dental, orthodontic and oral pharmaceutical products.

SouthLight Healthcare

SouthLight Healthcare is a nonprofit organization that provides outpatient and community-based services for mental health and substance use treatment. They empower the journey through prevention, education, and innovative treatment solutions delivered ...